Gastrointestinal cancer
Explore our latest news, features and educational resources in this specialist area.
Trifluridine–tipiracil not recommended for metastatic gastric cancer or gastro-oesophageal junction adenocarcinoma
Rifluridine–tipiracil does not meet NICE's criterion to be considered a life-extending treatment at the end of life.
5-fluorouracil (intravenous), capecitabine, tegafur: DPD testing recommended before initiation to identify patients at increased risk of severe and fatal toxicity
Patients with complete or partial dihydropyrimidine dehydrogenase (DPD) deficiency are at increased risk of severe and fatal toxicity during treatment with these medicines.
